Opella Healthcare Group Sas, A Sanofi Company
Clinical trials sponsored by Opella Healthcare Group Sas, A Sanofi Company, explained in plain language.
-
Early allergy pill may stop sneezing before it starts
Symptom relief CompletedThis study tested whether taking the allergy drug fexofenadine for two days before ragweed season can reduce symptoms like sneezing and runny nose. 95 adults with ragweed allergies were randomly given either fexofenadine or a placebo. Researchers measured nasal symptoms over six …
Phase: PHASE3 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Symptom relief
Last updated Jun 26, 2026 15:14 UTC
-
Magne-B6 gets a makeover: new tablet tested against old liquid
Knowledge-focused CompletedThis study tested whether a new tablet form of Magne-B6 releases magnesium and vitamin B6 into the body as well as the current liquid version. Twenty-four healthy adults took both forms in random order and had their blood and urine levels measured. The goal was to see if the tabl…
Phase: PHASE1 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:53 UTC
-
Can you take this allergy pill without water? new study investigates
Knowledge-focused CompletedThis study tested a new version of the allergy drug fexofenadine (Allegra) to see if it is absorbed well when taken with or without water. 25 healthy adults each received six different treatments in random order. The goal was to compare the new tablet to the standard coated table…
Phase: PHASE1 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:50 UTC